🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us in thanking our lab staff as we celebrate Lab Week 2025! CEO Tom Schoenherr reminds us: “We don’t just appreciate our lab staff and all they do this week, but every single day. Thank you for all your hard work and dedication and the value that this team brings to Ambry.”

We asked Hazel Diuri-Lee what a clinical operations specialist does at Ambry. This team supports the smooth and efficient functioning of clinical operations, including tasks like data management and quality assurance for clinical trials and genetic testing services. When I

We’re continuing our track record of scientific innovation and discoveries with our latest hereditary cancer menu and reporting updates. Our peer-reviewed, published gene-disease validity (GDV) scheme enables the enhanced assessment and characterization of RPS20 for

At Ambry Genetics, Laboratory Directors play a crucial role in solving diagnostic mysteries by overseeing various aspects of genetic testing and variant assessment and through implementation of new technologies and methodologies that enhance the accuracy and efficiency of genetic

This article from NPR highlights the challenges of traditional mammogram-only cancer screening for women with dense breast tissue. The Ambry CARE Program® can account for breast density when calculating the Tyrer-Cuzick breast cancer risk score. CARE enables health systems to

We are looking forward to seeing you at the 2025 SBI Breast Imaging Symposium! Join us at booth 447 to discover how you can elevate your imaging practice and make a bigger impact in your community! The Ambry CARE Program® (CARE) is streamlining #breastcancer risk assessment and

We’re excited to see Ambry’s experts featured in GenomeWeb highlighting how structural biology can take variant interpretation to the next level. Using tools like AlphaFold and AlphaMissense, these studies showcase practical, accessible methods for understanding the impact of

Jeni Herrera-Mullar MGC, CGC, DMA and Principal Clinical Scientist at Ambry Genetics shows why RPS20 is a bona fide, high penetrance gene for #colorectalcancer predisposition in this “Top 20” poster from #ACMG2025. This science and data, in combination with medical management

Every April during Lab Week, we pause to celebrate the people whose work powers every test result, every insight, and every life changed through genetic testing. At Ambry Genetics, that celebration runs deep—because it truly takes a village. This year for Lab Week, we are

On National DNA Day, we honor the incredible advancements in genetic science that are transforming lives. Every discovery brings us closer to a future where care is tailored to each patient. At Ambry, we’re proud to be at the forefront of this movement, partnering with providers

Ambry Genetics is a proud sponsor of the 2025 ACOG Annual Scientific Meeting. We invite you to visit us at booth 1543 to learn about Ambry's Hereditary Cancer Testing (hubs.ly/Q03jj1dd0) and CARE (hubs.ly/Q03jh-Yg0)—our high-risk identification program.

Join us for a webinar Wednesday, April 30, at 11 am PDT. hubs.ly/Q03jXTb50

Join Ambry in celebrating Patient Experience Week with Heather Fecteau, MS, CGC as she demonstrates one way we put patients first. CARE was developed with patient experience at front of mind, empowering patients to become engaged partners in their own healthcare journeys. #CARE

We are headed to Las Vegas for the American Society of Breast Surgeons Annual Meeting! Come see us at Booth 624 May 1-3. We look forward to seeing you there to discuss how #genetictesting for #hereditarycancer risk and The Ambry #CARE Program® can impact your practice and give

Join Ambry at #BRCA2025 in Quebec. We are looking forward to meeting with you and discussing the insights, achievements, and challenges of hereditary breast and ovarian cancer. For the latest clinical insights, don't miss our breakfast symposium and scientific posters.

Don't miss any of Ambry's scientific posters and presentations at #BRCA2025. We look forward to seeing you there! #SettingtheStandard #breastcancer #genetictesting hubs.ly/Q03lcnWM0

By conducting family health history assessments and recommending genetic testing when appropriate, OB/GYNs can help identify patients at risk for certain cancers, paving the way to early intervention and personalized care plans. And the process can be streamlined and simple to

Are you attending the #BRCA2025 Symposium in Montreal this week? Several of Ambry's clinical experts are attending and would love to meet you at our booth! Stop by to ask questions or sign up for a specific time to chat here: hubs.ly/Q03lm5nd0 Carrie Horton: Clinical

Rachel Bluebond, MMSc, CGC, discusses the data-driven enhancements behind Ambry's latest hereditary cancer updates—powered by Ambry Classifi®.

Today is World Ovarian Cancer Day Ovarian cancer affects thousands of patients and their families worldwide every year. While it’s often called the "silent disease" due to its subtle symptoms, together, we can give it a voice. Early detection saves lives. If you have a history